.png)
Neteera
Contactless radar-on-chip continuous vital-signs monitoring
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Neteera is positioned as a regulated contactless patient-monitoring company using radar/sub-THz sensing, with a clear focus on healthcare deployment and expansion beyond core monitoring use cases. Its strategic direction appears centered on converting deep technical differentiation into broader clinical adoption and multi-market commercialization.
Efficiency Ratio
The company shows strong innovation output and certification progress relative to a modest reported headcount and funding base, indicating solid technical efficiency but still mid-stage commercial scale.
Evidence Signals
FDA cleared and CE certified (NB 2797) for continuous contactless patient monitoring.
Closed a ~$6.7M Series B extension on October 31, 2023.
Listed as deployed in over 400 healthcare facilities, with more than 35,000 systems active across the United States, indicating customer traction and operating partnerships.
Flagship solution Neteera 130H-Plus uses low-power high-frequency radar to measure respiratory rate, heart rate, and motion through clothing and bedding.
Company profile indicates 51-200 employees on LinkedIn and about 70 employees in PitchBook, suggesting a small-to-mid-sized operating base.
Technology stack is described as radar/sub-THz micro-radar-on-chip with AI-enabled continuous monitoring and privacy-preserving, non-camera sensing.
- About
- Israeli medical-device company (Jerusalem-based Neteera Technologies Ltd.; US entity Neteera US Inc. in Lewes, Delaware), founded in 2015 by a group of high-tech veterans including CEO Isaac Litman (former CEO of Mobileye Aftermarket). Its micro-radar-on-chip (116–123 GHz CMOS) plus AI algorithms sense the skin's micro-movements to continuously measure vital signs — heart rate, respiratory rate, HRV, tidal volume — contactlessly through clothing and bedding at up to 1.5 m, with no cameras or microphones. FDA-cleared and CE-certified. Used in nursing homes, home care, hospitals and telemedicine; applicable to unobtrusive casualty/patient monitoring in the C12 prolonged-field-care thread. Defense relevance is commercial-first.
- Tags
- #radar #contactless #vitals #rpm #cmos #sensoronchip #fda #monitoring #dualuse